Daimler Truck AG (President and CEO: Karin Rådström, hereafter “Daimler Truck”) Mitsubishi Fuso Truck and Bus Corporation (President and CEO: Karl Deppen, hereafter “Mitsubishi Fuso”), Hino Motors Ltd. (President and CEO: Satoshi Ogiso, hereafter “Hino”) and Toyota Motor Corporation (President and CEO: Koji Sato, hereafter “Toyota”) today concluded Definitive Agreements for the integration of Mitsubishi Fuso and Hino. This press release features multimedia. View the full release here: https://...

In response to Harbour BioMed’s recent press release regarding a procedural development in their ongoing legal claim, Biocytogen issues the following statement: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617098086/en/Figure 1. Biocytogen’s RenNano® Platform Genetic Engineering Strategy (Source: https://biocytogen.com/antibody-drug-development/rennano） Biocytogen stands by its core values of independent innovation, respect for...

EnterpriseDB (EDB), the leading Postgres data and AI company, today announced new innovations to the EDB Postgres AI (EDB PG AI) platform designed to help enterprises deploy and scale AI securely and compliantly across their Postgres environments, whether in clouds or on-premises. The platform streamlines operations at scale, integrates easily with existing data ecosystems, and centralizes hybrid management and observability in a single AI-ready control plane for the emerging era of agentic AI....

Tecnotree, a global digital platform and services leader for AI-enabled 5G and cloud-native technologies, has been named a Representative Vendor in the 2025 Gartner® Market Guide for CSP B2B Digital Marketplace Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250519187602/en/Tecnotree Recognized in Gartner® Market Guide for CSP B2B Digital Marketplace Solutions The report highlights the strategic role of digital marketplaces...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today will present new data from the Arm C and D cohorts of the pivotal, global Phase 3 SEQUOIA trial of BRUKINSA® (zanubrutinib). The findings underscore the strong and consistent efficacy of BRUKINSA across CLL patient types, including high-risk mutation status. These data will be presented in two rapid oral presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. ...

HCLTech, a leading global technology company, has been selected by ASISA, a prominent health insurance provider in Spain, as its strategic IT partner to accelerate business transformation and expansion in Iberia. This partnership aims to accelerate ASISA's digital transformation journey to enhance the experience for its 2.2 million customers and position the company at the forefront of innovation in the region. HCLTech will modernize ASISA's IT platforms and leverage AI-based solutions to enh...